Silica Corpora
Company Overview
Silica Corpora is a cutting-edge biotech company specializing in AI-driven antibody design and optimization for therapeutic applications. Founded in 2022 and headquartered in Berlin, Germany, the company leverages proprietary AI and machine learning technologies to develop novel antibody candidates targeting priority diseases, improving efficiency, precision, and control in the drug discovery process.
Technology and Mission
Silica Corpora's platform uses AI models trained on amino acid sequences to generate high-quality antibody candidates and optimize their properties. Its modular system includes technologies such as Generator, Discriminator, Optimizer, and Ep-Mapper, aiming to enhance the quality and cost-effectiveness of antibody therapeutics for diseases with high unmet medical needs. The company is committed to transforming drug discovery by reducing the time and cost associated with bringing new prescription drugs to market.
Collaborations
Silica Corpora partners strategically with entities like Berkeley Skydeck, SIB, Charité, Google Cloud, Exist, 5HT, and Fraunhofer to drive innovation and expand their impact in the biotech industry.
Jobs
Open job positions can be found on their careers page: https://www.silica-corpora.ai/careers
The company's LinkedIn page is: http://www.linkedin.com/company/silica-corpora/
